[1]
“Detection and Management of Signals Associated with Adverse Drug Reactions from Atorvastatin and Rosuvastatin: An Observational Study”, VER, vol. 8, no. 17s, pp. 279–284, Dec. 2025, Accessed: Aug. 28, 2026. [Online]. Available: https://verjournal.com/index.php/ver/article/view/1272